RMTI

Rockwell Medical, Inc.

7.99 USD

Last updated Sep 4, 20:13 UTC

Yesterday HIGH

$8.06

Yesterday LOW

$7.85

52w HIGH

$19.1

52w LOW

$4.88

EPS

-0.40

PE

-19.96

Next Earnings

Nov 11, 2026

Overview News Government Trades Fundamentals

Rockwell Medical, Inc. stock is up 9.99% since 30 days ago. The next earnings date is Nov 11, 2026. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 34.48% of the previous 28 September’s closed higher than August.

Webmaster

Wed Jul 1, 2026

Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Webmaster

Tue Jun 30, 2026

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending
Benzinga Newsdesk

Mon Jun 29, 2026

Rockwell Medical shares are trading lower after the company announced a 1-for-10 reverse split of issued and outstanding common stock.
Benzinga Newsdesk

Mon Jun 29, 2026

Rockwell Medical Plans 1-for-10 Reverse Stock Split Next Week

Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today
Nabaparna Bhattacharya

Wed May 20, 2026

What's Going On With Rockwell Medical Stock Wednesday?

Rockwell Medical (RMTI) spikes 6.4% premarket. Discover key support and resistance levels as the stock tests its 20-day moving average.
Benzinga Newsdesk

Wed May 20, 2026

Rockwell Medical Extends Long-Term Supply Agreement With aQua Dialysis For Dialysis Concentrates And Related Products
Benzinga Newsdesk

Wed May 20, 2026

Rockwell Medical Renews And Extends Its Product Purchase Agreement With aQua Dialysis

The Agreement, which includes supply and purchasing commitments, will be in effect for two years with options to renew for two additional one-year periods. Under the Agreement, Rockwell Medical will continue to supply
Benzinga Newsdesk

Thu May 14, 2026

Rockwell Medical Signs Three-Year Product Purchase Agreement With Heritage Dialysis

Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today
Benzinga Newsdesk

Thu May 7, 2026

Rockwell Medical Raises FY2026 Sales Guidance from $65.000M-$70.000M to $70.000M-$75.000M vs $73.769M Est

Rockwell Medical updates its 2026 annual guidance as follows: 2026 Annual GuidanceNet Sales$70.0M to $75.0MGross Margin18% to 22%Adjusted EBITDA$1.0M to $2.0MOperating Cash FlowPositive
Benzinga Newsdesk

Thu May 7, 2026

Rockwell Medical Q1 Adj. EPS $(0.01) Beats $(0.03) Estimate, Sales $17.336M Miss $17.954M Estimate

Rockwell Medical (NASDAQ:RMTI) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.03) by 50 percent. This is unchanged from the same period last year. The company reported